HIGHLIGHTS
- who: Aida Kalantari and colleagues from the University, UNITED STATES have published the paper: Robust performance of a live bacterial therapeutic chassis lacking the colibactin gene cluster, in the Journal: PLOS ONE of 22/09/2022
- what: A subsequent NHP study was designed to assess whether the deletion of pks in the phenylalanine-consuming strain SYNB1934 has a significant impact on in_vivo activity. The results presented in this work demonstrate that the removal of pks does not alter the transit and clearance kinetics or the engineered therapeutic function of the EcN strains. To that end . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.